Clinical Trial Update: Topical Tacrolimus in Vernal Keratoconjunctivitis [Phase 4]

View source ↗

Summary

An update on a Phase 4 trial evaluating topical tacrolimus for Vernal keratoconjunctivitis, with the study status listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vernal Keratoconjunctivitis

Drugs mentioned

• Tacrolimus (topical) (tacrolimus)

Snippet

Sponsor: The Eye Center and The Eye Foundation for Research in Ophthalmology | Conditions: Vernal Keratoconjunctivitis | Phase 4 | Status: UNKNOWN